BioCentury
ARTICLE | Finance

Ebb & Flow

December 3, 2001 8:00 AM UTC

German investors are growing uneasy over one main source of certain cash to biotech and high tech companies. The state backed technology investment bank - Technologiebeteiligungsgesellschaft (tbg) - is keeping tight lipped about its reluctance to make further investments in venture stage companies.

Biotech industry insiders are reporting rumors that tbg is now turning down funding deals that would have been positively supported in the past. "In fact," said a German VC who did not want to be named, "the bank appears to have ceased doing deals at all."...